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ABSTRACT: Chain-end-labeled polymers are interesting for a range of
applications. In polymer nanomedicine, chain-end-labeled polymers are
useful to study and help understand cellular internalization and
intracellular traﬃcking processes. The recent advent of ﬂuorescent label-
free techniques, such as nanoscale secondary ion mass spectrometry
(NanoSIMS), provides access to high-resolution intracellular mapping that
can complement information obtained using ﬂuorescent-labeled materials
and confocal microscopy and ﬂow cytometry. Using poly(N-(2-
hydroxypropyl)methacrylamide) (PHPMA) as a prototypical polymer
nanomedicine, this paper presents a synthetic strategy to polymers that
contain trace element labels, such as ﬂuorine, which can be used for
NanoSIMS analysis. The strategy presented in this paper is based on
reversible addition fragmentation chain transfer (RAFT) polymerization of
pentaﬂuorophenyl methacrylate (PFMA) mediated by two novel chain-
transfer agents (CTAs), which contain either one (α) or two (α,ω) ﬂuorine labels. In the ﬁrst part of this study, via a number of
polymerization experiments, the polymerization properties of the ﬂuorinated RAFT CTAs were established. 19F NMR
spectroscopy revealed that these ﬂuorinated RAFT agents possess unique spectral signatures, which allow to directly monitor
RAFT agent conversion and measure end-group ﬁdelity. Comparison with 4-cyanopentanoic acid dithiobenzoate, which is a
standard CTA for the RAFT polymerization of PFMA, revealed that the introduction of one or two ﬂuorine labels does not
signiﬁcantly aﬀect the polymerization properties of the CTA. In the last part of this paper, a proof-of-concept study is presented
that demonstrates the feasibility of the ﬂuorine-labeled poly(pentaﬂuorophenyl methacrylate) polymers as platforms for the
postpolymerization modiﬁcation to generate PHPMA-based polymer nanomedicines.
■ INTRODUCTION
Polymers containing labels, such as ﬂuorescent dyes, are of
interest for a myriad of applications. One example of the use of
ﬂuorescent-labeled polymers is in polymer nanomedicine.
Fluorescent-labeled polymers are extensively used to monitor
internalization and intracellular traﬃcking of polymers and
polymer nanoparticles. A number of strategies have been
developed for the synthesis of ﬂuorescent-labeled polymers,
which lead to incorporation of the dye label either as a side-
chain functionality or at the chain end.1 Chain-end labeling is
very attractive since only a very small number of dye labels are
required and the polymer side chains are frequently used to
anchor bioactive cargo.1
Controlled radical polymerization techniques are very
powerful tools for the preparation of chain-end-labeled
polymers as they preserve reactive polymer chain ends
throughout the polymerization reaction.1 Reversible addition
fragmentation chain transfer (RAFT) polymerization, in
particular, is a very attractive method for the preparation of
chain-end-labeled polymers that are to be used as polymer
nanomedicines or for other biological applications.2 The RAFT
polymerization method is characterized by an exceptional
functional group tolerance.2,3 By adjusting the nature of the R
and Z groups of the chain-transfer agent (CTA), RAFT
polymerization can be used to generate polymers that contain
functional groups at the α- and ω-chain ends.2−6 Fluorescent
chain-end-labeled polymers have been prepared by RAFT
polymerization by reduction of the CTA-derived end group,
followed by reaction with a maleimide-modiﬁed ﬂuorescent
dye.7 Alternatively, the thiol end groups on polymers obtained
by RAFT polymerization have been reacted with cystamine,
followed by coupling of an NHS ester ﬂuorescent dye.8
Although they have been extensively used to monitor and
study cellular uptake and intracellular traﬃcking of polymers
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and polymer nanoparticles, ﬂuorescent dyes also have some
drawbacks and limitations. Exposure of polymer−dye con-
jugates or dye-loaded nanoparticles to the highly degradative
intracellular environment can result in release of the dye.9,10
Another potential limitation is the risk for pH- and
concentration-dependent quenching or photobleaching.9−12
Finally, the ﬂuorescent dye may alter the uptake or
internalization properties of the polymer13 and/or inﬂuence
intracellular processes.14
Over the past years, the number of techniques available to
study cell uptake and intracellular traﬃcking of polymers and
polymer nanoparticles has increased and now also includes
several methods that do not require the use of ﬂuorescently
labeled polymers.15 Raman spectroscopy, for example, uses
vibrational labels, often isotopes,16−19 and nanoscale secondary
ion mass spectrometry (NanoSIMS) allows the intracellular
tracking of trace elements or isotopes.20−22 Synchrotron X-ray
ﬂuorescence imaging has also been used to visualize elements
and metals in cellular environments.23−25 As a consequence,
there is an increasing demand for simple and eﬃcient methods
to label polymers with isotopes and trace elements. Among the
various trace elements or isotopes that are available, ﬂuorine is
very attractive as it gives rise to minimal steric alterations and
possesses a high metabolic stability.26 A number of techniques
have been developed, which take advantage of these favorable
attributes of ﬂuorine, such as Fluoro-Raman spectroscopy27,28
and 19F-magnetic resonance imaging (19F-MRI). In the
literature, a number of side-chain-ﬂuorinated polymers have
been reported, which were used for 19F-MRI studies.29,30
One possible strategy for the preparation of ﬂuorine-end-
labeled polymers is via RAFT polymerization using ﬂuorinated
CTAs. There are a number of reports in the literature that
describe the use of ﬂuorinated RAFT agents. Fluorinated
RAFT agents have been used in the polymerization of a variety
of monomers, including ethyl acrylate, styrene, methyl
methacrylate, butyl acrylate, vinyl pyrrolidone, vinyl chloride,
and vinyl acetate. In most instances, the introduction of
ﬂuorine was explored to modulate the reactivity of the RAFT
agent.31−37 In other examples, ﬂuoralkyl-functionalized RAFT
agents were used to prepare polymers and copolymers with
perﬂuorinated end groups.38,39 These chain-end-ﬂuorinated
polymers were used as additives to modify the surface
properties of the corresponding nonﬂuorinated polymers.39
So far, the use of ﬂuorinated RAFT CTAs for the
polymerization of active ester monomers has not been
explored. This approach, however, would oﬀer a number of
opportunities for the preparation of polymer nanomedicines.
First, since the ﬂuorine labels are only introduced at the chain
end(s) of the resulting polymers, any impact on the solution
properties of the polymers is expected to be negligible/reduced
compared to the use of side-chain-ﬂuorinated polymers.
Second, while the ﬂuorine-chain-end-functional groups can
be exploited as labels for bioimaging purposes, the active ester
side chains can be utilized for further postpolymerization
modiﬁcation reactions to introduce, for example, bioactive
cargo. Finally, due to its unique sensitivity, ﬂuorine labeling of
the RAFT agent may also allow to directly monitor RAFT
agent conversion and end-group ﬁdelity of the produced
polymers by 19F NMR spectroscopy.
In this paper, we describe the preparation of ﬂuorine-chain-
end-labeled side-chain-reactive polymers via RAFT polymer-
ization of pentaﬂuorophenyl methacrylate (PFMA). PFMA is a
side-chain-reactive monomer, which can be polymerized via
RAFT polymerization and which is widely used for the
Chart 1. Chemical Structures of 4-Cyanopentanoic Acid Dithiobenzoate (CTA-1), R-Labeled CTA (F-CTA-1), and R−Z-
Labeled CTA (F-CTA-2)
Scheme 1. Synthesis of Fluorinated End-Labeled PPFMA Using F-CTA-1 and F-CTA-2
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preparation of reactive polymer precursors.40,41 For the RAFT
polymerization, two diﬀerent ﬂuorinated chain-transfer agents
(CTAs) were used, which contain either one (R) or two (R,Z)
ﬂuorine labels. After investigating the feasibility of the two
ﬂuorinated RAFT agents to mediate the polymerization of
PFMA, the postpolymerization modiﬁcation of the resulting
poly(pentaﬂuorophenyl methacrylate) (PPFMA) polymers to
generate α-ﬂuorine, ω-Rhodamine Red end-labeled poly(N-(2-
hydroxypropyl)methacrylamide) (PHPMA) will be reported.
PHPMA is interesting as a proof of concept since this polymer
has been widely used for the preparation of polymer−drug
conjugates.42−53
■ RESULTS AND DISCUSSION
Design and Synthesis of the Fluorinated CTAs.
Eberhardt et al. investigated the RAFT polymerization of
PFMA using cumyl dithiobenzoate and 4-cyanopentanoic acid
dithiobenzoate as chain-transfer agents.51 Both CTAs have an
activating phenyl Z group and a good tertiary cumyl or
cyanopentanoic acid leaving radical R•, which are suitable for
activated monomers, such as methacrylates. These studies
revealed that 4-cyanopentanoic acid dithiobenzoate was a more
eﬀective chain-transfer agent for the RAFT polymerization of
PFMA compared to cumyl dithiobenzoate.51 4-Cyanopenta-
noic acid dithiobenzoate (here after referred to as CTA-1)
since then has been extensively used for the RAFT polymer-
ization of PFMA43,44,46,47 and also served as the precursor and
starting point for the design of the ﬂuorinated CTAs
Figure 1. Example of a 19F NMR spectrum of α-ﬂuorinated PPFMA obtained using F-CTA-1. Polymerization conditions: dioxane; 75 °C; [M]0 =
1.8 M; [M]0:[F-CTA-1]0 = 100, [F-CTA-1]0:[I]0 = 10; polymerization time, 300 min. The inset is a magniﬁcation of a selected area of the
spectrum to highlight the polymer-derived 19F NMR signals (A−E).
Figure 2. (A) First-order kinetic plot for the RAFT polymerization of PFMA as determined by 19F NMR spectroscopy. Polymerization conditions:
dioxane; 75 °C; [M]0 = 1.8 M; [CTA]0:[I]0 = 10; [M]0:[CTA-1]0 = 200 (□); and [M]0:[F-CTA-1]0 = 200 (■). (B) Evolution of experimental Mn
and Mw/Mn as a function of monomer conversion for CTA-1 as determined by SEC (□) and F-CTA-1 as determined by SEC (■) and
19F NMR
(▲). SEC analysis was performed using THF as solvent and PS standards were used for conventional calibration. The dotted lines (CTA-1) and
dashed lines (F-CTA-1) indicate the expected theoretical Mn (Mn
TH).
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investigated in this study. The chemical structures of CTA-1
and the two ﬂuorinated derivatives investigated in this study
are shown in Chart 1. While F-CTA-1 contains a
triﬂuoromethyl label in the R group, F-CTA-2 contains two
triﬂuoromethyl labels in both the R and the Z groups. The
synthesis of F-CTA-1 and F-CTA-2 is presented in Scheme S1.
A number of factors were taken into account for the selection
of ﬂuorinated labels as well as their position in the CTA. First
of all, to be able to characterize the polymer end groups and to
monitor the progress of the polymerization by 19F NMR
spectroscopy, two diﬀerent labels are needed with 19F NMR
chemical shifts that overlap neither with each other nor with
those of the PFMA units of the monomer or polymer. A
second prerequisite is that the introduction of the labels should
not aﬀect the polymerization process (vide infra). F-CTA-1
was obtained in a single step via N-(3-dimethylaminopropyl)-
N′-ethylcarbodiimide (EDC)-mediated coupling of CTA-1
with 3,3,3-triﬂuoropropylamine hydrochloride. Compared to
F-CTA-1, F-CTA-2 contains a triﬂuoromethylphenyl Z-group
as a second ﬂuorine label. Previous work has shown that the
introduction of electron-withdrawing groups (such as triﬂuor-
omethyl) on the phenyl Z-group of dithioester CTAs increases
the activity of the RAFT agent and resulted in narrow
molecular-weight distributions at low conversion.34 The
remainder of this paper will ﬁrst discuss the RAFT polymer-
ization of PFMA with F-CTA-1 and investigate the eﬀect of
various reaction parameters, such as temperature and the [M]0:
[CTA]0 ratio (Scheme 1). After that, the optimal RAFT
polymerization conditions that have been identiﬁed using F-
CTA-1 will be used in the F-CTA-2-mediated RAFT
polymerization of PFMA.
F-CTA-1-Mediated Polymerization of PFMA. RAFT
polymerization of PFMA mediated by CTA-1 is generally
performed in dioxane using monomer concentrations ([M]0)
of 2 M, [CTA]0:[I]0 ratios of 8−1044,47,51,52 as well as
relatively low reaction temperatures (65−75 °C)47,52,53 and
long polymerization times (up to 42 h).47 To the best of our
knowledge, however, a detailed study of the polymerization
kinetics of PFMA under these conditions has not been
reported. Eberhardt et al. reported the kinetics of the RAFT
polymerization of PFMA using CTA-1 at a monomer
concentration of ∼2 M and a 8:1 [CTA]0:[I]0 ratio. These
polymerizations were carried out at 90 °C, and the highest
obtained molecular weight (Mn) was around 10 000 g/mol.
51
In the present study, ﬁrst a set of experiments was performed
to investigate and compare the kinetics of the RAFT
polymerization of PFMA with CTA-1 and F-CTA-1. These
polymerizations were carried out in dioxane at 75 °C using
2,2′-azobis(2-methylpropionitrile) (AIBN) as the initiator at
[M]0 = 1.8 M, [CTA]0:[I]0 = 10, and [M]0:[CTA]0 = 200.
Polymerization reactions were monitored by 19F NMR
spectroscopy. An example of a 19F NMR spectrum of an
aliquot taken from a polymerization reaction is shown in
Figure 1. The spectrum illustrates the unique sensitivity of 19F.
Due to the diﬀerence in chemical shift of the free and
polymerized PFMA as well as that between the free and
polymer-bound F-CTA-1 agent, not only the monomer
conversion but also the consumption of the RAFT agent,
can be directly determined from the 19F NMR spectra.
Furthermore, comparison of the integrals of the ﬂuorinated
polymer end groups to that of the PPFMA side chains provides
the degree of polymerization. Monomer conversion ρ (%) was
determined by 19F NMR spectroscopy, taking advantage of the
diﬀerence in 19F NMR chemical shifts of the pentaﬂuorophenyl
ester groups in the monomer (c, d, e) and polymer (C, D, E)
as shown in Figure 1. The monomer conversion at a given
polymerization time was determined using eq 1 by comparing
the area of the polymer peaks to that of the remaining
monomer peaks indicated in Figure 1 as E and e, respectively.
E
E e
(%) 100
∫
∫ ∫
ρ =
+
×
(1)
Subsequently, the monomer conversion ρ, the initial [M]0:
[CTA]0 ratio, and the number of initiator (AIBN)-derived side
chains (df([I]0 − [I])) were used to calculate the theoretical
degree of polymerization, as shown in eq 2.54 df([I]0 − [I])
was expressed as df [I]0(1 − e−kdt), where kd is the rate constant
for initiator decomposition at 75 °C (7.33 × 10−5 s−1) and 90
Figure 3. Double-logarithmic plot of [F-CTA-1] vs [M] as
determined by 19F NMR spectroscopy. The experimental points
were ﬁtted using eq 4. Polymerization conditions: dioxane; 75 °C;
[M]0 = 1.8 M; [M]0:[F-CTA-1]0 = 200; [F-CTA-1]0:[I]0 = 10.
Table 1. Ctr and C−tr Values for the Diﬀerent PFMA Polymerization Conditions Using F-CTA-1 and F-CTA-2
F-CTA [M]0 (mol/L) [M]0:[F-CTA]0 [F-CTA]0:[I]0 temperature (°C) Ctr
a C−tr
a
F-CTA-1 1.8 200 10 75 3.0 400.0
100 10 75 3.2 390.0
90 4.1 399.9
50 10 75 3.5 390.0
90 4.7 391.0
F-CTA-2 100 10 90 4.0 390.1
50 10 90 4.8 370.1
aDetermined using eq 4.
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°C (4.79 × 10−4 s−1),55 f is the initiator eﬃciency, which is
assumed to be 0.6 ( f = 0.6),55−57 and d is the number of chains
produced in a radical−radical termination event. Since this
value is not available for this speciﬁc system, the value reported
for MMA was used (d = 1.67).56,57 The theoretical molecular
weights (Mn
TH) were calculated taking into account the
monomer (mM) and the CTA (mCTA) molecular weights as
given in eq 3. Experimental molecular weights of the polymers
obtained using both CTA-1 and F-CTA-1 for the diﬀerent
polymerization times were determined by size exclusion
chromatography (SEC) analysis using tetrahydrofuran
(THF) as solvent and polystyrene (PS) as standard. While
this eluent and standard have been previously used for the SEC
analysis of PPFMA,45 the hydrodynamic properties of PPFMA
and PS in THF may not be comparable. As illustrated by
Figure 1, however, 19F NMR spectroscopy can be used to
validate the SEC molecular weights. 19F NMR number-average
molecular weights (Mn) were determined by comparing the
integrals of the 19F NMR signal generated by the three ﬂuorine
atoms at the α-end group of PPFMA (A in Figure 1) to that of
the PFMA polymer side chains (E).
df
DP
M
CTA I (1 e )k t
TH 0
0 0
d
ρ= [ ]
[ ] + [ ] − − (2)
M DP mM mCTAn
TH TH= × + (3)
Figure 2 and Table S1 summarize the results of the analysis of
RAFT polymerization experiments of PFMA with CTA-1 and
F-CTA-1, which were carried out in dioxane at 75 °C, [M]0 =
1.8 M, [CTA]0:[I]0 = 10, and [M]0:[CTA]0 = 200. For both
the CTA-1- and F-CTA-1-mediated RAFT polymerization of
PFMA, ﬁrst-order kinetic plots were obtained (Figure 2A) and
in both cases, the experimental polymer molecular weights
were found to increase linearly with monomer conversion. Also
the polydispersities of polymers produced with the two
diﬀerent RAFT agents were comparable and slightly decreased
with increasing monomer conversion (Figure 2B). The
relatively good agreement between the results obtained using
CTA-1 and F-CTA-1 suggests that the modiﬁcation of CTA-1
with a ﬂuorine label does not seem to inﬂuence the reactivity
of the RAFT agent toward the polymerization of PFMA. For
both the CTA-1- and F-CTA-1-mediated RAFT polymer-
ization, especially in the early stages of the polymerization,
however, it was observed that the experimental molecular
weights were higher than the theoretical predictions. This,
together with relatively high polydispersity values (>1.5) in the
early stages of the polymerization process, indicates a slow
consumption of the CTAs. The relatively slow consumption of
the CTAs is also evident from the 19F NMR spectra shown in
Figure 1. In this spectrum, the 19F signal due to the CF3 group
of the nonreacted F-CTA-1 can be clearly observed next to
that of the F-CTA-1, which has been incorporated in the
polymer. In an ideal case, the degree of polymerization at a
particular polymerization time is expressed as ([M]0 − [M]):
[CTA]0. Therefore, a CTA that is slowly consumed generates
polymer chains having an experimental molecular weight
higher than expected. The early stage of the CTA-1- and F-
CTA-1-mediated polymerization of PFMA therefore proceeds
via a hybrid free-radical RAFT mechanism.34,57,58 As the
polymerization time increases, the higher CTA conversion
shifts the process toward a RAFT mechanism and the
experimental molecular weights converge toward the theoreti-
cal values.
Determination of the Transfer Constants Ctr and C−tr
of F-CTA-1. To assess the eﬃciency of F-CTA-1, the transfer
constants Ctr (=ktr/kp) and C−tr (=k−tr/kiR), which take into
account the reactivity of the propagating radical Pn
• and the
Figure 4. (A) First-order kinetic plots for the RAFT polymerization
of PFMA as determined by 19F NMR spectroscopy. Polymerization
conditions: dioxane; 75 °C; [M]0 = 1.8 M; [M]0:[F-CTA-1]0 = 200
(■), 100 (●), and 50 (○); and [F-CTA-1]0:[I]0 = 10. (B) Evolution
of experimental Mn and Mw/Mn as a function of monomer conversion
for [M]0:[F-CTA-1]0 = 100 as determined by SEC (●) and
19F NMR
(▲) and (C) [M]0:[F-CTA-1]0 = 50 as determined by SEC (○) and
19F NMR (Δ). SEC analysis was performed using THF as solvent and
PS standards were used for conventional calibration. The dashed lines
indicates the theoretical Mn (Mn
TH) expected for the diﬀerent
conditions.
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reactivity of the expelled radical R•, were determined from the
decay of the CTA concentration during the polymerization
using the following equation54,56,58
C
C C 2
d CTA
d M
CTA
M CTAtr tr tr
[ ]
[ ]
≈ [ ]
[ ] + [ ] + [ ]− (4)
where [CTA] and [M] are the CTA and monomer
concentrations at a particular polymerization time, respectively,
and [2] is the concentration of dormant polymer chains, which
can be directly related to the [CTA] and the initial CTA
concentration [CTA]0. Hence, if both monomer and CTA
consumptions can be experimentally determined at each
polymerization time, eq 4 can be ﬁtted using independent
pairs of input Ctr and C−tr.
56,57,59 Usually, CTA conversion is
estimated by comparing the found and theoretically expected
number-average molecular weights.56 For some RAFT agents,
CTA conversion has been directly monitored by 1H NMR
spectroscopy, but for others, overlap with resonances due to
the polymer often prevents the use of 1H NMR analysis.60 As
shown in Figure 1, 19F NMR spectroscopy is a powerful
method to directly monitor CTA conversion. The 19F label in
F-CTA-1 allows to distinguish between free (the signal labeled
as “a” in Figure 1) and bound CTA (the signal labeled as “A”
in Figure 1) and thus to directly determine F-CTA-1
consumption by 19F NMR analysis. As an example, Supporting
Information Figures S1−S4 show 19F NMR spectra of samples
taken from the F-CTA-1-mediated polymerization of PFMA at
[M]0:[CTA]0 = 50 at 20, 40, 60, and 120 min polymerization
time, which illustrate the consumption of the CTA with
increasing reaction time. Figure 3 plots the evolution of F-
CTA-1 conversion with increasing monomer conversion in a
double-logarithmic fashion for a RAFT polymerization of
PFMA with F-CTA-1 at [M]0:[CTA]0 = 200 and [CTA]0:[I]0
= 10 at a polymerization temperature of 75 °C. Fitting of the
experimental data with eq 4 allowed the determination of Ctr
and C−tr, which were found to be 3 and 400, respectively. For a
RAFT polymerization to display the typical characteristics of a
“living”/controlled polymerization reaction, a Ctr of at least 10
is required.58 Very eﬀective RAFT agents usually have Ctr >
100. In an attempt to improve control of the polymerization, a
number of further experiments, in which the [M]0:[F-CTA-1]0
ratio (from 200 to 100 and 50) as well as the polymerization
temperature (90 °C instead of 75 °C) was varied, were
performed and Ctr and C−tr were determined using the same
procedure. Table 1 lists the Ctr and C−tr values determined
from these experiments. The corresponding plots of ln[F-
CTA-1] versus ln[M] and the respective ﬁts are included in
Supporting Information Figure S5. The results in Table 1
suggest a minor increase in Ctr upon increasing the
polymerization temperature as well as upon decreasing [M]0:
[CTA]0 at a given temperature. Analysis of the corresponding
polymerization kinetics, as well as of the evolution of polymer
molecular weight and polydispersity upon decreasing [M]0:
[CTA]0 or increasing the polymerization temperature to 90
°C, however, still points toward a hybrid-type polymerization
behavior and no signiﬁcant improvement in Mw/Mn was
observed (see Figure 4 for T = 75 °C and Supporting
Information Figure S6 for T = 90 °C).
RAFT Polymerization of PFMA Using F-CTA-2.
F‑CTA‑2 contains a ﬂuorinated label in both the R(α) and
Z(ω) groups. As illustrated in Figure 5, the ﬂuorinated chain
ends derived from the R and Z groups of F-CTA-2 give rise to
diﬀerent 19F NMR chemical shifts. This is attractive as it does
not only allow to use 19F NMR spectroscopy to directly
monitor F-CTA-2 consumption during polymerization, but
also to assess end-group ﬁdelity by comparison of the integrals
associated to the α (A) and ω (B) chain-end-terminal CF3
groups. Polymerization experiments with F-CTA-2 were
carried out at 90 °C using both [M]0:[CTA]0 = 100 and
[M]0:[CTA]0 = 50. Table S2 summarizes the results of these
experiments, and Figure 6 shows the polymerization kinetics as
well as evolution of polymer molecular weight for these
polymerization experiments. The polymerization kinetics using
F-CTA-2 were slightly slower compared to the F-CTA-1-
mediated polymerization of PFMA (see Supporting Informa-
tion Figure S6). Similar to what was observed for F-CTA-1,
the experimental molecular weights, in particular at low
monomer conversion, were higher than the expected polymer
molecular weights. To explain these observations, Ctr and C−tr
were determined as discussed above for F-CTA-1. Examples of
19F NMR spectra of the polymers obtained using [M]0:[CTA]0
= 50 are reported in Supporting Information Figures S7−S10.
Figure 5. Example of an 19F NMR spectrum of α,ω-ﬂuorinated PPFMA obtained using F-CTA-2. Polymerization conditions: dioxane, 90 °C, [M]0
= 1.8 M, [M]0:[F-CTA-2]0 = 100, [F-CTA-2]0:[I]0 = 10, polymerization time 240 min.
ACS Omega Article
DOI: 10.1021/acsomega.8b01654
ACS Omega 2018, 3, 9710−9721
9715
The resulting Ctr and C−tr values for F-CTA-2 were 4.0 and
390.1 and 4.8 and 370.1 for [M]0:[CTA]0 = 100 and 50,
respectively (Table 1). These numbers are close to those
obtained for F-CTA-1 at the same polymerization temperature,
which indicates that (i) the introduction of a ﬂuorinated label
at the Z-group of F-CTA-2 does not signiﬁcantly aﬀect the
reactivity of F-CTA-2 compared to that of F-CTA-1 and (ii)
the polymerization of PFMA with F-CTA-2 is best described
as a hybrid free-radical RAFT polymerization process (as it was
the case for F-CTA-1, as discussed above).
The diﬀerence in 19F NMR chemical shifts of CF3 groups A
and B in F-CTA-2 can be used to assess the end-group ﬁdelity
of the PPFMA polymers produced with this CTA (Figure 5).
The end-group ﬁdelity, expressed as ω/α ratio, was calculated
directly using the integrals derived from the A (α) and B (ω)
ﬂuorine peaks incorporated in the polymer. It should be
mentioned that due to the presence of initiator-derived side
chains, the ω/α values might be slightly overestimated;
however, in general, when high [CTA]0:[I]0 ratios are used,
the extent of polymer chains lacking α-end-group function-
alities can be neglected.61 The obtained ω/α ratios for the two
polymerization conditions for the diﬀerent polymerization
times are reported in Table 2. It was found that for both
conditions, the initial ω/α ratios were close to unity and only
slightly decreased up to values around 0.86 upon increasing the
polymerization time. This suggests that only a minor loss of ω-
end groups might occur during the course of the polymer-
ization.
Postpolymerization Modiﬁcation. After studying the
ability of F-CTA-1 and F-CTA-2 to mediate the RAFT
polymerization of PFMA, the postpolymerization modiﬁcation
of the resulting polymers to generate double chain-end-labeled
PHPMA polymers containing a 19F label at the α-terminus and
a Rhodamine Red label at the other chain end was assessed
(Scheme 2). To this end, the α-ﬂuorinated PPFMA precursor
(Mn = 30 200 g/mol by SEC) was ﬁrst postmodiﬁed with 1-
amino-2-propanol to give the corresponding α-ﬂuorinated
PHPMA derivative. Comparison of the 19F NMR spectra of
the PPFMA precursor (Figure 7A) and the corresponding
PHPMA derivative (Figure 7B) suggests quantitative ami-
nolysis of the side-chain pentaﬂuorophenyl ester groups.
Subsequently, the ω PHPMA end groups were reduced and
the resulting thiol moieties reacted with a maleimide-
Rhodamine Red dye via Michael addition. While an excess
of 1-amino-2-propanol was used in the ﬁrst reaction step, the
thiol−maleimide coupling of the rhodamine dye was found to
proceed much more eﬃcient after an additional NaBH4-
mediated reduction, which indicates that presumably not all
thioester end groups were cleaved via aminolysis by 1-amino-2-
propanol. The 19F NMR spectra of the α-ﬂuorinated PPFMA
Figure 6. (A) First-order kinetic plot for the F-CTA-2-mediated
RAFT polymerization of PFMA as determined by 19F NMR
spectroscopy. Polymerization conditions: dioxane; 90 °C; [M]0 =
1.8 M; [M]0:[F-CTA-2]0 = 100 (●) and 50 (○); [F-CTA-2]0:[I]0 =
10. (B) Evolution of experimental Mn and Mw/Mn as a function of
monomer conversion for [M]0:[F-CTA-2]0 = 100 as determined by
SEC (●) and 19F NMR (▲) and (C) [M]0:[F-CTA-2]0 = 50 as
determined by SEC (○) and 19F NMR (Δ). SEC analysis was
performed using THF as solvent, and PS standards were used for
conventional calibration. The dashed lines indicate the theoretical Mn
(Mn
TH) expected for the diﬀerent conditions.
Table 2. ω/α End-Group Ratios Determined via 19F NMR
Spectroscopy for the Diﬀerent PFMA Polymerization Times
Using F-CTA-2, [M]0:[F-CTA-2]0 = 100 and 50, and T = 90
°C
[M]:[F-CTA-2] time (min) ω/α
100 20 0.97
40 1.07
60 0.97
120 0.88
180 0.87
240 0.91
50 20 0.95
40 0.9
60 0.92
120 0.86
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precursor, the α-ﬂuorinated PHPMA, and the α-ﬂuorinated
PHPMA−rhodamine conjugate are shown in Figure 7. The
percentage of end-group functionalization with the ﬂuorescent
dye was determined by UV spectroscopy measurements using
the calibration curve reported in Figure S12 and was estimated
to be 80%.
■ CONCLUSIONS
19F-labeled PHPMA polymers are a potentially interesting
platform to generate polymer nanomedicines whose cellular
internalization and intracellular traﬃcking can be monitored
using ﬂuorescent label-free techniques, such as NanoSIMS. A
ﬁrst important step toward such polymers is to develop
synthetic protocols that allow access to these 19F chain-end-
labeled materials. This paper has elaborated a synthetic
strategy that is based on the RAFT polymerization of PFMA,
mediated by two new RAFT CTAs that contain either 1 (F-
CTA-1) or 2 (F-CTA-2) 19F-labels, followed by postpolyme-
rization modiﬁcation of the PFMA side-chain functional
groups. The polymerization properties of the ﬂuorinated
CTAs were investigated in depth and compared to that of 4-
cyanopentanoic acid dithiobenzoate (CTA-1), which is
frequently used for the RAFT polymerization of PFMA. 19F
NMR spectroscopy revealed that these two RAFT agents
possessed unique chemical shifts that allowed to directly
monitor CTA conversion (as well as to determine end-group
ﬁdelity). It was found that the introduction of 1 or 2 ﬂuorine
labels does not signiﬁcantly alter the polymerization behavior
of the CTAs. For both CTA-1 and the two ﬂuorinated
analogues, the polymerization of PFMA was found to proceed
via a hybrid free-radical RAFT mechanism. 19F NMR analysis
of polymers produced using F-CTA-2 revealed end-group
ﬁdelities of ∼90%. These 19F-labeled reactive PPFMA
polymers are attractive precursors for the synthesis of
PHPMA-based polymer nanomedicines. As a ﬁrst proof of
concept, an α-19F-labeled PPFMA was converted via a three-
step postpolymerization strategy into an α-19F, ω-Rhodamine
Red-labeled PHPMA polymer. Access to such double-labeled
polymers is crucial to further the understanding of the cellular
internalization and intracellular traﬃcking of polymer−drug
conjugates. While the Rhodamine Red label allows to monitor
uptake via ﬂow cytometry or confocal microscopy, the 19F label
opens the way to high-resolution mapping of intracellular
pathways using NanoSIMS.
■ EXPERIMENTAL SECTION
Materials. All chemicals were used as received unless
described otherwise. 4-Cyanopentanoic acid dithiobenzoate
(CTA) (>97%), N-(3-dimethylaminopropyl)-N′-ethylcarbodii-
mide hydrochloride (EDC·HCl) (97%), and 2,2′-azobis(2-
methylpropionitrile) (98%) (AIBN), which was recrystallized
from methanol prior use, tris(2-carboxyethyl)phosphine hydro-
chloride (TCEP), 1-amino-2-propanol, sodium borohydride
(NaBH4), Sephadex G 15, and 1,8-diazabicyclo[5.4.0]undec-7-
ene (DBU) were purchased from Sigma-Aldrich. 1,4-Dioxane
Scheme 2. Synthesis of α-Fluorinated, ω-Rhodamine Red-Labeled PHPMA
Figure 7. 19F NMR spectra of (A) α-ﬂuorinated PPFMA, (B) α-
ﬂuorinated, and (C) α-ﬂuorinated, ω-Rhodamine Red−PHPMA
conjugate. The inset in (C) shows the UV−vis spectrum of the α-
ﬂuorinated, ω-Rhodamine Red−PHPMA conjugate, which was
recorded in dimethyl sulfoxide at a concentration of 0.07 mg/mL.
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and triethylamine (Et3N) were purchased from Acros
Organics, and 3,3,3-triﬂuoropropylamine hydrochloride was
obtained from Apollo Scientiﬁc. Rhodamine Red C2
maleimide was purchased from Life Technologies. Pentaﬂuor-
ophenol was purchased from Matrix Scientiﬁc. Dichloro-
methane (DCM), tetrahydrofuran (THF), hexane, and ethyl
acetate were purchased from Reactolab. Sodium methoxide
(30% solution in methanol), elemental sulfur, 4-chlorobenzo-
triﬂuoride, and 4,4′-azobis(4-cyanovaleric acid), which was
crystallized from ethanol, were purchased from J&K Scientiﬁc
Ltd. Pentaﬂuorophenyl methacrylate (PFMA) was synthesized
as reported by Eberhardt et al.42 1,4-Dioxane was dried over
molecular sieves, and Et3N was freshly distilled prior use. THF
was dried using a Pure Solv solvent puriﬁcation system prior
use.
Methods. NMR Spectroscopy. 1H and 19F NMR spectra
were recorded on a Bruker AV-400 instrument at room
temperature using CDCl3 as solvent.
1H NMR chemical shifts
are reported relative to the residual proton signal of the
solvent.
Size Exclusion Chromatography (SEC). Size exclusion
chromatography (SEC) was performed using an Agilent
1260 inﬁnity system equipped with a Varian 390-LC refractive
index detector, two PLgel 5 μm Mixed C (Agilent) columns,
and a PLgel guard column. THF was used as eluent with a ﬂow
rate of 1 mL/min, and the temperature was 40 °C. The
samples were analyzed using conventional calibration with
polystyrene (PS) standards ranging from 4910 Da to 549 kDa.
UV−vis Spectroscopy. The incorporation of Rhodamine
Red C2 maleimide on the polymer was quantiﬁed using a
Varian Cary 100 Bio spectrometer using quartz cuvettes.
Procedures. Synthesis of F-CTA-1. The synthesis of F-
CTA-1 is outlined in Scheme S1A. 4-Cyanopentanoic acid
dithiobenzoate (CTA-1, 500.0 mg, 1.79 mmol) and (EDC·
HCl) (411.6 mg, 2.15 mmol) were dissolved in 8 mL of dry
DCM, and the solution was cooled down to 0 °C and stirred
under nitrogen. In a second ﬂask, 214.0 mg (1.43 mmol) of
3,3,3-triﬂuoropropylamine hydrochloride was dissolved in 8
mL of dry DCM and 250 μL (1.43 mmol) of triethylamine was
added. After 10 min, the 3,3,3-triﬂuoropropylamine solution
was added dropwise to the ﬁrst solution and the reaction was
stirred at room temperature for 2 h. After that, the solution was
washed with 5% NaHCO3 and brine, dried over MgSO4, and
ﬁnally dried under vacuum. The crude product was puriﬁed by
ﬂash chromatography using ethyl acetate/hexane 4.5:5.5 to
give a dark pink product (73% yield). 1H, 13C, and 19F NMR
spectra of F-CTA-1 are included in Figures S13−S15. The
electrospray ionization (ESI) mass spectrum image is shown in
Figure S16. Anal. calcd for C16H17F3N2OS2: C, 51.32; N, 7.48;
H, 4.58. Found: C, 52.58; N, 7.41; H, 4.93.
Synthesis of F-CTA-2. The synthesis of F-CTA-2 is outlined
in Scheme S1B. Under a dry, nitrogen atmosphere, a ﬂask was
charged with 69.4 g of 30% sodium methoxide solution (0.39
mol), followed by 13.3 g of anhydrous methanol and ﬁnally
rapid addition of 5.4 g (0.17 mol) of elemental sulfur. The
mixture was heated in an oil bath at 70 °C with continuous
stirring for 30 min. After that, 15.0 g (0.08 mol) of 4-
(chloromethyl)benzotriﬂuoride was added dropwise via an
addition funnel over a period of 1 h. The reaction mixture was
kept at 70 °C under a nitrogen atmosphere for 10 h. After this
time, the reaction was stopped by cooling down to 0 °C using
an ice bath. The salt was removed by ﬁltration, and the solvent
was removed in vacuum. Then, 50 mL of deionized water was
added to the residue and the solution was ﬁltered again. The
crude product was washed with diethyl ether (3 × 40 mL) in
an extraction funnel. Diethyl ether (20 mL) and 1.0 M HCl
(50 mL) were added, and the product was extracted into the
ethereal layer. Deionized water (30 mL) and 1.0 M NaOH (60
mL) were added and the product was extracted to the aqueous
layer. Potassium ferricyanide(III) (36.3 g, 0.11 mol) was
dissolved in 100 mL of deionized water and then added
dropwise to the ﬁrst solution via an addition funnel over a
period of 1 h under vigorous stirring. Then, the solution was
transferred to an extraction funnel. Anhydrous ethyl acetate
(30 mL) was added to wash the product, and the product was
extracted to the ethyl acetate layer. This washing process was
repeated two more times. The red solution was dried over
anhydrous MgSO4 and in vacuum to remove the solvent at
room temperature overnight. The resulting 4,4′-di-triﬂuor-
omethyl-di(thiobenzoyl) disulﬁde was dissolved in 50 mL of
anhydrous ethyl acetate, and the solution was transferred to a
ﬂask. Dry 4,4′-azobis(4-cyanovaleric acid) (2.6 g, 9.19 mmol)
was added to the ﬂask, and the reaction solution was heated at
75 °C for 14 h. After that, the ethyl acetate was removed under
vacuum and the crude product was puriﬁed by column
chromatography using ethyl acetate:hexane (1:1.5) as eluent.
The solvent mixture was removed in vacuum and the red oily
4-cyanopentanoic acid-4-(triﬂuoromethyl) dithiobenzoate
(75% yield with respect to 4-(chloromethyl)benzotriﬂuoride)
was kept at 4 °C. Next, 2.0 g (5.8 mmol) of 4-cyanopentanoic
acid-4-(triﬂuoromethyl) dithiobenzoate and 1.34 g (6.96
mmol) of EDC·HCl were dissolved in 20 mL of dry DCM.
The solution was cooled down to 0 °C and stirred under
nitrogen. In a second ﬂask, 0.7 g (4.60 mmol) of 3,3,3-
triﬂuoropropylamine hydrochloride was dissolved in 10 mL of
dry DCM and 465 μL (4.60 mmol) of triethylamine was
added. After 10 min, the triﬂuoropropylamine solution was
added dropwise to the ﬁrst solution and the reaction was
stirred at room temperature for 2 h. The solution was washed
with 5% NaHCO3 solution and brine, dried over anhydrous
MgSO4, and dried under vacuum. The crude product was
puriﬁed by column chromatography using ethyl acetate/hexane
1:1.5 to give 0.5 g (25% yield with respect to 4-cyanopentanoic
acid-4-(triﬂuoromethyl) dithiobenzoate) of the dark pink F-
CTA-2. We note that these reaction conditions are not
optimized. The low yield of this last step compared to the same
reaction for the preparation of F-CTA-1 is most likely due to
loss of material during workup and puriﬁcation. 1H, 13C, and
19F NMR spectra of F-CTA-2 are included in Figures S17−
S19. The ESI mass spectrum is shown in Figure S20. Anal.
calcd for C17H16F6N2OS2: C, 46.15; N, 6.33; H, 3.65. Found:
C, 46.95; N, 6.31; H, 3.36.
RAFT Polymerization of PFMA. PFMA (1.4 g, 5.56 mmol)
was added to a Schlenk tube, followed by 2.08 mL of dry
dioxane containing 0.0028, 0.0055, or 0.011 mmol AIBN and
0.028, 0.055, or 0.11 mmol CTA in the case of [M:CTA] =
200, 100, and 50, respectively. The solutions were degassed by
four freeze−pump−thaw cycles, and the tubes were ﬁlled with
argon. The ﬂasks were immersed in an oil bath at 90 °C or 75
°C. At diﬀerent time intervals, 150 μL aliquots were removed,
50 μL were diluted in 400 μL CDCl3 for
19F NMR analysis,
and the remaining part was precipitated in ice-cold hexane
three times. The isolated pink product was dried under
vacuum overnight and analyzed by SEC.
Synthesis of α-Fluorinated PHPMA. α-Fluorinated PPFMA
(100 mg; Mn = 30 200 g/mol by SEC, 0.397 mmol PFMA
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reactive units) was dissolved in 5 mL of dry dimethylforma-
mide (DMF) (1H and 19F NMR spectra of this polymer are
included in Supporting Information Figures S21 and S22).
Then, 2 equiv (61 μL, 0.794 mmol) 1-amino-2-propanol and 2
equiv (110 μL, 0.794 mmol) Et3N were added and the reaction
was stirred at 50 °C for 20 h. The product was isolated by
three precipitations in ice-cold diethyl ether and subsequently
dialyzed against water and lyophilized. The 1H NMR spectrum
of the resulting α-ﬂuorinated PHPMA is included in Figure
S11.
Synthesis of α-Fluorinated PHPMA−Rhodamine Conju-
gate.Modiﬁcation of the polymer end groups with Rhodamine
Red was performed as previously reported with some
modiﬁcations.7 First, 20 mg (0.00129 mmol end groups) of
α-ﬂuorinated PHPMA (Mn = 17 200 g/mol, calculated from
the Mn of the precursor α-ﬂuorinated PPFMA) was dissolved
in 3 mL of an aqueous 0.5 M NaBH4 solution and stirred at
room temperature for 2 h. After that, the solution was dialyzed
against water for 48 h and the product was lyophilized. In a
second step, 10 mg of the product (0.60 μmol end groups) was
dissolved in dry DMF, 5 equiv (0.8 mg, 0.0032 mmol) of
neutralized TCEP were added, and the solution was stirred
overnight under argon. After 20 h, 5 equiv (2.1 mg) of
Rhodamine Red C2 maleimide was added together with one
drop of DBU. The solution was stirred under argon at room
temperature for another 24 h. The solution was dialyzed
against water overnight using a SpectraPor (molecular weight
cut-oﬀ, 3.5 kDa) membrane to remove the DMF and ﬁnally
lyophilized. The product was puriﬁed by passing it through a
Sephadex G 15 column. The puriﬁcation was repeated twice.
The percentage of end-group functionalization was estimated
using the calibration curve reported in Figure S12, assuming
that the extinction coeﬃcient of the polymer-bound Rhod-
amine Red is the same as that of the corresponding free dye.
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